EHA HIGHLIGHTS 2024 – LEUKEMIA ROUNDTABLE DISCUSSION: SECONDARY-TYPE MUTATIONS IN ELN 2022 FAVORABLE RISK AML & RESULTS FROM THE HARMONY PLATFORM

EHA HIGHLIGHTS 2024 – LEUKEMIA ROUNDTABLE DISCUSSION: SECONDARY-TYPE MUTATIONS IN ELN 2022 FAVORABLE RISK AML & RESULTS FROM THE HARMONY PLATFORM

EHA Highlights 2024 Roundtable Discussions
Pre-Video Survey
Post-Video Survey
Icon Chair Speaker

Chair

Dr. Jorge Cortes

Icon Chair Speaker

Panelists

Dr. Julie Bergeron
Dr. Aniket Bankar

This program has been made possible through unrestricted support from Astellas.

Studies/trials discussed:

  • GENOMIC LANDSCAPE OF ADULT AML WITH T(8;21)(Q22;Q22.1) AND PROGNOSTIC IMPLICATIONS – RESULTS FROM THE HARMONY PLATFORM
  • ADVERSE PROGNOSTIC IMPACT OF SECONDARY-TYPE MUTATIONS IN ELN 2022 FAVORABLE RISK ACUTE MYELOID LEUKEMIA
Tagged